APLS — APELLIS PHARMACEUTICALS INC

Ownership history in Squarepoint Ops LLC  ·  23 quarters on record

This page tracks every 13F SEC filing in which Squarepoint Ops LLC reported a position in APELLIS PHARMACEUTICALS INC (APLS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.03% (2022 Q3)
Avg. % of fund
0.01%
First filed
2018 Q3
Last filed
2025 Q4
Quarters held
23
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 192,156 +139,322 +263.7% 0.01% $4.8M $25.12
2025 Q3 ADDED 52,834 +25,834 +95.7% 0.00% $1.2M $22.63
2025 Q3 REDUCED 27,000 -302,392 -91.8% 0.00% $611K $22.63
2025 Q2 REDUCED 329,392 -113,401 -25.6% 0.01% $5.7M $17.31
19 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    APLS price (monthly, adj. close)

Other funds also holding APLS

As of 2025 Q4 — sorted by position size

Deep Track Capital, LP 3Y 3.47% Avoro Capital Advisors LLC 3Y 7Y 3.02% SUVRETTA CAPITAL MANAGEMENT, LLC 3Y 7Y 2.13% Siren, L.L.C. 1.93% RTW INVESTMENTS, LP 3Y 7Y 1.93% Exome Asset Management LLC 1.63% Logos Global Management LP 3Y 1.52% Kynam Capital Management, LP 3Y 1.46% ORBIMED ADVISORS LLC 3Y 7Y 1.25% SPHERA FUNDS MANAGEMENT LTD. 3Y 7Y 1.22%
← Back to Squarepoint Ops LLC Holdings